Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 154, Issue -, Pages 113602
Publisher
Elsevier BV
Online
2022-08-25
DOI
10.1016/j.biopha.2022.113602
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer
- (2021) Zhili Wen et al. Aging-US
- Quiescin Sulfhydryl Oxidase 1 Promotes Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving EGFR Endosomal Trafficking and Inhibiting NRF2 Activation
- (2021) Jialei Sun et al. Redox Biology
- The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles
- (2021) Jun-O. Jin et al. Marine Drugs
- MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma
- (2021) Peng Xia et al. Cell Death & Disease
- Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
- (2021) Francesca Fornari et al. Journal of Hepatocellular Carcinoma
- Structural characterization of a P-selectin and EGFR dual-targeting fucoidan from Sargassum fusiforme
- (2021) Xue Liu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Study on Absorption Mechanism and Tissue Distribution of Fucoidan
- (2020) Xu Bai et al. MOLECULES
- Fucoidan Induces Apoptosis of HT-29 Cells via the Activation of DR4 and Mitochondrial Pathway
- (2020) Xu Bai et al. Marine Drugs
- Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance
- (2020) María Elena Reyes et al. Marine Drugs
- miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
- (2020) Lin Ji et al. Cell Death & Disease
- A review on fucoidan antitumor strategies: From a biological active agent to a structural component of fucoidan-based systems
- (2020) Catarina Oliveira et al. CARBOHYDRATE POLYMERS
- Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of TGFβ-mediated Slug expression
- (2020) Wei-Lun Qiu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Multifunctional role of fucoidan, sulfated polysaccharides in human health and disease: A journey under the sea in pursuit of potent therapeutic agents
- (2020) Biswajita Pradhan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
- (2019) Geert van Weelden et al. Marine Drugs
- Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor
- (2019) Xuezhu Rong et al. Journal of Thoracic Oncology
- “Fucoidan, a natural biopolymer in cancer combating: From edible algae to nanocarrier tailoring”
- (2019) Samar M. Etman et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Therapies from Fucoidan: New Developments
- (2019) Fitton et al. Marine Drugs
- EGFR-mediated autophagy in tumourigenesis and therapeutic resistance
- (2019) Min Wu et al. CANCER LETTERS
- miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway
- (2018) Rongchang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation
- (2018) Qiong Wu et al. Cell Death & Disease
- Mannan-binding lectin deficiency exacerbates sterile liver injury in mice through enhancing hepatic neutrophil recruitment
- (2018) Jia Zhou et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway
- (2018) Junru Li et al. OncoImmunology
- Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo
- (2017) Yuan Yan et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation
- (2017) Huifang Li et al. Virology Journal
- Heterogeneity of liver cancer and personalized therapy
- (2016) Liang Li et al. CANCER LETTERS
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prophylactic Administration of Fucoidan Represses Cancer Metastasis by Inhibiting Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinases (MMPs) in Lewis Tumor-Bearing Mice
- (2015) Tse-Hung Huang et al. Marine Drugs
- Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR
- (2015) T Bertrand et al. Cell Death & Disease
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
- (2014) Letizia Porcelli et al. CURRENT DRUG TARGETS
- Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
- (2013) Toni M. Brand et al. PLoS One
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells
- (2011) Wei-Chien Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
- (2010) Mary E. Irwin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nuclear EGFR contributes to acquired resistance to cetuximab
- (2009) C Li et al. ONCOGENE
- Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in JB6 Cl41 cells
- (2008) Na Yeon Lee et al. FOOD AND CHEMICAL TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More